DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Indian Terrain Fashions Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 2 hrs ago·8 Oct 2026, 12:26 pm

IND Terrain Fashions

Indian Terrain Fashions Limited has informed stock exchanges that it has obtained a certificate under SEBI's (Depositories and Participants) Regulations, 2018. This regulatory filing is a standard compliance requirement for listed companies to ensure their shareholding patterns are accurate and up-to-date.

For investors, this news is largely procedural and does not signal any immediate operational or financial change for the company. It confirms that the company is adhering to market regulations regarding the maintenance of its shareholding data, which is essential for transparency.

Moving forward, the focus will likely remain on the company's core business performance and quarterly results. Investors should watch for updates on the company's financial health and any broader market developments that might impact its stock price.